Literature DB >> 23244237

Serum concentration and kidney expression of salusin-α and salusin-β in rats with metabolic syndrome induced by fructose.

I Sahin1, S Aydin.   

Abstract

Salusins expressed in a variety of tissues exert a hypotensive effect owing to their vasodilator action. They are found in serum and tissues in two different forms: salusin-α and salusin-β. Metabolic syndrome (MetS) is an important public health problem characterized by diabetes, obesity, abnormal blood lipid levels and high blood pressure. We investigated how salusins in the circulation and in kidney tissues change in relation to MetS. Experiments were conducted on 5-week-old Sprague-Dawley male rats assigned to either a control group or a MetS group. Controls were fed standard rat food and water ad libitum, while the MetS group was fed standard food with 10% fructose solution added to their drinking water for three months. After three months, all animals were sacrificed after a one night fast. Blood and tissues were collected and stored appropriately. Biochemical parameters were analyzed using the Konelab 60 auto-analyzer. Salusin-α and salusin-β levels in the blood and kidneys were studied using the ELISA method. The salusin expression in the renal tissue was shown by immunohistochemical staining. Compared to the control group, the MetS group showed elevated uric acid and other lipid parameters for high-density lipoprotein cholesterol. Serum salusin-α and salusin-β levels were decreased; however, salusin levels/mg kidney tissue were elevated. Immunohistochemical analysis of salusins in kidney tissue revealed their presence in the epithelium cells of the glomeruli, and proximal and distal tubule cells. The expression of both peptides in renal tissues was greater in the MetS group than in the control group. We believe that salusins are critical mediators in the etiopathology of MetS. Altered salusin levels are thought to regulate hypertension, which is a component of MetS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23244237     DOI: 10.3109/10520295.2012.744848

Source DB:  PubMed          Journal:  Biotech Histochem        ISSN: 1052-0295            Impact factor:   1.718


  4 in total

1.  Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes.

Authors:  Suleyman Aydin; Tuncay Kuloglu; Suna Aydin; Mehmet Nesimi Eren; Musa Yilmaz; Mehmet Kalayci; Ibrahim Sahin; Nevin Kocaman; Cihan Citil; Yalcin Kendir
Journal:  Mol Cell Biochem       Date:  2013-04-26       Impact factor: 3.396

Review 2.  Salusins: potential use as a biomarker for atherosclerotic cardiovascular diseases.

Authors:  Kengo Sato; Rena Watanabe; Fumiko Itoh; Masayoshi Shichiri; Takuya Watanabe
Journal:  Int J Hypertens       Date:  2013-10-22       Impact factor: 2.420

3.  Downregulation of Salusin-β protects renal tubular epithelial cells against high glucose-induced inflammation, oxidative stress, apoptosis and lipid accumulation via suppressing miR-155-5p.

Authors:  Hongmei Chen; Genjuan Jin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

4.  Salusin-β mediates tubular cell apoptosis in acute kidney injury: Involvement of the PKC/ROS signaling pathway.

Authors:  Qing-Bo Lu; Qiong Du; Hui-Ping Wang; Zi-Han Tang; Yuan-Ben Wang; Hai-Jian Sun
Journal:  Redox Biol       Date:  2019-12-20       Impact factor: 11.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.